Danaher Corporation
Danaher Announces Fourth Quarter 2025 Estimated Financial Performance
Summary
On January 12, 2026, Danaher Corporation announced its estimated financial performance for the fourth quarter of 2025. The company expects mid-single digit year-over-year revenue growth and non-GAAP core revenue growth toward the high-end of its previously announced low-single digit percentage guidance. Full-year 2025 non-GAAP adjusted diluted net earnings per common share are anticipated to be toward the high-end of the $7.70 to $7.80 guidance range. CEO Rainer M. Blair commented on the solid finish to 2025 and the company's position for long-term value creation. Danaher's presentation slides and press release can be found on the 'Investors' section of its website.
Profitelligence Alerts
Get alerts for DHR
Be first to know when Danaher Corporation files with the SEC.
Filing Categories
Advertisement
About Danaher Corporation
Danaher Corporation is a globally recognized science and technology company specializing in the development, design, and manufacturing of diverse industrial and healthcare products. With a primary focus on innovations in diagnostics, life sciences, dental, and environmental and applied solutions, Danaher serves a multitude of industries and market sectors. Its cutting-edge diagnostic equipment aids medical professionals in delivering precise healthcare, while its life sciences tools and technologies propel biomedical research and development. The company's environmental solutions also play a key role in enhancing water quality analysis and management. Headquartered in Washington, D.C., Danaher is renowned for its strong operational culture exemplified by the Danaher Business System (DBS), which emphasizes continuous improvement and sustainable innovation. This approach has solidified Danaher's presence and influence in both developing specialized solutions and improving efficiency across global markets. The company's strategic acquisitions and consistent focus on innovation have positioned it as a leader in delivering essential solutions that drive significant improvements for healthcare, research, and industrial clients.
Official SEC Documents
Advertisement